semaglutide supply shortage news november 2025 Novo's Wegovy and Ozempic removed from US FDA list, compounders on notice US judge upholds FDA's removal

Physical address

In this episode of "Every Body Knows," I sit down with naturopath Christina Mathewson to explore the carnivore diet and its potential to support the management of chronic illnesses

Extreme high-temperature conditions can increase body temperature and adversely impact mammalian biological functions, leading to impaired production and reproductive traits 38,39

Not just chemistry, but biology, precision design, and regulatory depth are now becoming essential to compete in this space." Hari Kiran Chereddi, MD & CEO, HRV Pharma and NHG Pharma GLP-1 Patent Expiry Timeline and Market Dynamics The market opportunity is defined by several critical factors: Patent Expiration: Semaglutide's key patents expire globally by early 2026 Market Growth: Demand for obesity and diabetes treatments growing 12-14% year-over-year Healthcare Savings: Indian companies can save global healthcare systems billions through cost-effective alternatives Regulatory Access: Opportunities to develop biosimilars or complex generics for US and EU markets Beyond Cost Competition: Value-Based Differentiation The competitive landscape for GLP-1 drugs extends beyond traditional cost advantages that have historically defined Indian pharmaceutical success